Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naltrexone and Bupropion for Weight Loss and Smoking Cessation in Schizophrenia
NCT02736474Phase 4Completed
- Sponsor
- Shanghai Mental Health Center
- Start
- May 2016
- Primary completion
- Jul 2018
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of naltrexone, bupropion in obesity, nicotine dependence, sponsored by Shanghai Mental Health Center. Started May 2016; status: completed.
02
Drugs
naltrexonebupropion
03
Conditions
obesitynicotine dependence
Beyond the preview
Go deeper on NCT02736474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02736474.